Prevalence and Factors Associated with Microalbuminuria in Pediatric Patients with Type 1 Diabetes Mellitus at a Large Tertiary-Level Hospital in Botswana

被引:7
作者
Ramaphane, Tshireletso [1 ]
Gezmu, Alemayehu M. [1 ]
Tefera, Endale [1 ]
Gabaitiri, Lesego [2 ]
Nchingane, Seeletso [3 ]
Matsheng-Samuel, Motlalekgomo [3 ]
Joel, Dipesalema [1 ]
机构
[1] Univ Botswana, Fac Med, Dept Pediat & Adolescent Hlth, Bag UB00713, Gaborone, Botswana
[2] Univ Botswana, Fac Social Sci, Dept Stat, Gaborone, Botswana
[3] Princess Marina Hosp, Dept Pediat, Gaborone, Botswana
来源
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY | 2021年 / 14卷
关键词
microalbuminuria; diabetic nephropathy; type 1 diabetes mellitus; pediatrics diabetes; GLYCEMIC CONTROL; MICROVASCULAR COMPLICATIONS; MICRO ALBUMINURIA; BLOOD-PRESSURE; RISK-FACTORS; PROGRESSION; ADOLESCENTS; MACROALBUMINURIA; CHILDREN; ONSET;
D O I
10.2147/DMSO.S322847
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Microalbuminuria is considered the earliest sign of diabetic nephropathy among patients with type 1 diabetes mellitus (T1DM). The prevalence of microalbuminuria among African children with T1DM is reported to be high, yet its prevalence and population-specific risk factors in Botswana are not known. Aim: This study aimed to determine the prevalence of microalbuminuria among children and young adults with T1DM in Botswana and identify factors associated with microalbuminuria in this population. Methods: A retrospective cross-sectional study was conducted on 127 T1DM patients aged <24 years followed at a pediatric endocrinology clinic in Botswana from 2010 to 2017. Clinical, laboratory, and demographic data were collected using chart review and patient surveys. Descriptive statistics were reported as mean and standard deviation for continuous variables, and frequency and percentage for categorical variables. Prevalence of microalbuminuria was calculated as a simple proportion. Group comparison was done using twosample independent t-test, X-2-test, or Fisher's exact test and logistic regression to assess for associations. Level of significance was set at p<0.05. Results: There were a total of 71 (55.9%) females. The mean age was 18.7 (+/- 5) years and mean duration of T1DM was 6.6 (+/- 4.6) years. Most study participants were of African descent. The prevalence of microalbuminuria was 28.3%. Group comparison revealed gender (p= 0.040), duration of diabetes (p= 0.002), systolic blood pressure (p=0.003), baseline glycated hemoglobin (HbA1c) (p=0.009) and Tanner's stage (p=008) to be significantly associated with microalbuminuria. On binary logistic regression, only gender (p=0.039) and baseline HbA4c (p=0.039) were independently associated with the presences of microalbuminuria. Conclusion: This study identified a high prevalence of microalbuminuria among children and young adults with T1DM in Botswana and reaffirms the importance of early detection, glycemic control, and regular screening to prevent diabetic nephropathy.
引用
收藏
页码:4415 / 4422
页数:8
相关论文
共 30 条
  • [1] Early Diabetic Nephropathy and Retinopathy in Patients with Type 1 Diabetes Mellitus Attending Sudan Childhood Diabetes Centre
    Ahmed, Hana
    Elshaikh, Tayseer
    Abdullah, Mohamed
    [J]. JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [2] Occurrence of microalbuminuria in young people with Type 1 diabetes: importance of age and diabetes duration
    Alleyn, C. R.
    Volkening, L. K.
    Wolfson, J.
    Rodriguez-Ventura, A.
    Wood, J. R.
    Laffel, L. M. B.
    [J]. DIABETIC MEDICINE, 2010, 27 (05) : 532 - 537
  • [3] Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects - The Oxford Regional Prospective Study
    Amin, R
    Schultz, C
    Ong, K
    Frystyk, J
    Dalton, RN
    Perry, L
    Orskov, H
    Dunger, DB
    [J]. DIABETES CARE, 2003, 26 (05) : 1456 - 1461
  • [4] Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study
    Amin, Rakesh
    Widmer, Barry
    Prevost, A. Toby
    Schwarze, Phillip
    Cooper, Jason
    Edge, Julie
    Marcovecchio, Loredana
    Neil, Andrew
    Dalton, R. Neil
    Dunger, David B.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7646): : 697 - 701
  • [5] Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and Microalbuminuria An Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort
    de Boer, Ian H.
    Rue, Tessa C.
    Cleary, Patricia A.
    Lachin, John M.
    Molitch, Mark E.
    Steffes, Michael W.
    Sun, Wanjie
    Zinman, Bernard
    Brunzell, John D.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (05) : 412 - 420
  • [6] ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents
    Donaghue, Kim C.
    Marcovecchio, M. Loredana
    Wadwa, R. P.
    Chew, Emily Y.
    Wong, Tien Y.
    Calliari, Luis Eduardo
    Zabeen, Bedowra
    Salem, Mona A.
    Craig, Maria E.
    [J]. PEDIATRIC DIABETES, 2018, 19 : 262 - 274
  • [7] Pattern of long-term complications in Sudanese insulin-treated diabetic patients
    Elbagir, MN
    Eltom, MA
    Mahadi, EO
    Berne, C
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 30 (01) : 59 - 67
  • [8] Prevalence and risk factors for micro albuminuria in a population-based sample of children and adolescents with T1DM in Western Australia
    Gallego, Patricia Herold
    Bulsara, Max Kishor
    Frazer, Fiona
    Lafferty, Antony Richard
    Davis, Elizabeth Ann
    Jones, Timothy William
    [J]. PEDIATRIC DIABETES, 2006, 7 (03) : 165 - 172
  • [9] Diabetic complications and glycaemic control in remote North Africa
    Gill, G.
    Gebrekidan, A.
    English, P.
    Wile, D.
    Tesfaye, S.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2008, 101 (10) : 793 - 798
  • [10] Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study
    Giorgino, F
    Laviola, L
    Perin, PC
    Solnica, B
    Fuller, J
    Chaturvedi, N
    [J]. DIABETOLOGIA, 2004, 47 (06) : 1020 - 1028